The Cannabis-Tobacco Worm Turns
WASHINGTON – More Americans now support cannabis legalization than tobacco legality, according to two recent polls. That’s quite a turnaround for both tobacco, which...
Medical Marijuana is Good Enough for Most Oklahoma Voters
OKLAHOMA CITY – Voters in Oklahoma rejected a ballot initiative to legalize cannabis for adult use during a special election Tuesday by a margin...
From Grower to Shower: What’s Next for Canopy Growth Corporation?
SMITH FALLS, ONTARIO – Canopy Growth Corporation, one of the world’s largest cannabis cultivators and manufacturers, announced plans to lay off 35 percent of...
Twitter Allows Cannabis Advertisers to Promote in the U.S. and Canada
SAN FRANCISCO – Twitter announced a significant update to its Drugs and Drug Paraphernalia policy that will permit approved cannabis advertisers to target adults...
Missouri’s First Recreational Weekend Was a $12.7M Winner
JEFFERSON CITY, Mo. – During the first weekend of adult-use sales, the average recreational retailer saw more than $70,000 in revenue—eclipsing historical weekend medical...
Federal Judge Rules Firearm Ban for Cannabis Users Unconstitutional
OKLAHOMA CITY – The Second Amendment disallows disarming citizens simply because they use cannabis, according to a federal judge in Oklahoma.
In a 54-page decision...
Two Industry Salary & Job Reports See the Money Moving East
DENVER and SAN DIEGO – Salaries are on the rise by an average of five to ten percent and 2023 will see the addition...
Curaleaf Shrinks in 3 States While Akerna Exits Cannabis
WAKEFIELD, Mass., and DENVER – Two of the cannabis industry’s most visible public companies are taking dramatic measures to survive market volatility. Curaleaf Holdings...
Akerna Unloads 3 More Business Units in 2023
DENVER – POSaBIT has signed an agreement to acquire MJ Platform, Leaf Data Systems, and Ample Organics from Akerna in a $4-million cash deal....
FDA Issues Guidance for Clinical Research & Product Development
SILVER SPRING, M.D. – The Federal Drug Administration's (FDA) Center for Drug Evaluation and Research issued its final nonbinding recommendations for clinical cannabis research...
